<DOC>
	<DOC>NCT02718599</DOC>
	<brief_summary>To evaluate the effect of terlipressin infusion on systemic and hepatic hemodynamics during hepatobiliary surgery</brief_summary>
	<brief_title>Effect of Terlipressin Infusion on Systemic and Hepatic Hemodynamics During Hepatobiliary Surgery</brief_title>
	<detailed_description />
	<mesh_term>Terlipressin</mesh_term>
	<mesh_term>Lypressin</mesh_term>
	<criteria>Age &gt; 18 years. Any gender. ASA (American Society of Anesthesiologists) Classification( Class III) Patients undergoing elective hepatobiliary surgery. Benign and malignant disease. Written informed consent Preoperative renal failure (GFR &lt; 50 ml/min). Severe liver dysfunction (Child turcot Pugh grade C). Hyponatremia (&lt;132 mmol/l). Severe aortic regurgitation, severe mitral regurgitation, heart failure. Symptomatic coronary heart disease. Bradycardic arrhythmia (heart rate &lt; 60/min). Peripheral artery occlusive disease (clinical stadium IIIV). Uncontrolled arterial hypertension (Blood pressure &gt;160/100 mmHg despite intensive treatment). Present or suspected acute mesenteric ischemia. Septic shock with low cardiac output. Pregnancy.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
</DOC>